Insulet Corp.’s PODD groundbreaking Omnipod 5 Automated Insulin Delivery (“AID”) system (Omnipod 5) received the FDA’s approval for use by type 2 diabetes patients (ages 18 years and above).
The full U.S. market release of Omnipod 5 with Dexcom’s G7 CGM took place in June this year. Expanding global access to Omnipod 5 has been one of the top priorities for Insulet.
Question: How is the Omnipod system covered under Medicare now that my doctor and I are considering it to help control my diabetes? Answer: The Omnipod system is an insulin delivery system that allows ...
The continuous glucose monitor and the newest generation of the Omnipod pump are able to communicate with each other, helping diabetics eliminate both high and low blood sugars.